| Barbara Jean Brown, PHD | |
|
650 Pennsylvania Ave Se, Suite 440, Washington, DC 20003-4318 | |
| (202) 544-5440 | |
| (202) 544-3004 |
| Full Name | Barbara Jean Brown |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 39 Years |
| Location | 650 Pennsylvania Ave Se, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073626354 | NPI | - | NPPES |
| PSY1526 | Other | DC | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY1526 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capitolhill Consortium For Counseling And Consultation, Llc | 1951602796 | 15 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Global health insurer Allianz Worldwide Care has announced the launch of a new plan which offers a compliant solution for onshore healthcare to shipping companies affected by the Maritime Labour Convention 2006 (MLC 2006), commonly known as the "Seafarers' Bill of Rights". MLC 2006, which came into force in August 2013, requires shipping companies to provide comprehensive rights and protection to the world's 1.2 million seafarers, including the provision of a minimum level of healthcare cover.
A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory syndrome (MERS) coronavirus without getting sick-research that could shed light on how coronaviruses make the jump to humans and other animals.
Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
› Verified 6 days ago
| Entity Name | Capitolhill Consortium For Counseling & Consultation, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992965552 PECOS PAC ID: 1951602796 Enrollment ID: O20151221000254 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Global health insurer Allianz Worldwide Care has announced the launch of a new plan which offers a compliant solution for onshore healthcare to shipping companies affected by the Maritime Labour Convention 2006 (MLC 2006), commonly known as the "Seafarers' Bill of Rights". MLC 2006, which came into force in August 2013, requires shipping companies to provide comprehensive rights and protection to the world's 1.2 million seafarers, including the provision of a minimum level of healthcare cover.
A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory syndrome (MERS) coronavirus without getting sick-research that could shed light on how coronaviruses make the jump to humans and other animals.
Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Jean Brown, PHD 650 Pennsylvania Ave Se, Suite 440, Washington, DC 20003-4318 Ph: (202) 544-5440 | Barbara Jean Brown, PHD 650 Pennsylvania Ave Se, Suite 440, Washington, DC 20003-4318 Ph: (202) 544-5440 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Global health insurer Allianz Worldwide Care has announced the launch of a new plan which offers a compliant solution for onshore healthcare to shipping companies affected by the Maritime Labour Convention 2006 (MLC 2006), commonly known as the "Seafarers' Bill of Rights". MLC 2006, which came into force in August 2013, requires shipping companies to provide comprehensive rights and protection to the world's 1.2 million seafarers, including the provision of a minimum level of healthcare cover.
A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory syndrome (MERS) coronavirus without getting sick-research that could shed light on how coronaviruses make the jump to humans and other animals.
Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
› Verified 6 days ago
Dr. Leila Bremer, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1330 New Hampshire Ave Nw, Suite 106, Washington, DC 20036 Phone: 202-887-0404 | |
Dr. Chester Wayne Bullock Jr., PSYD, MED Psychologist Medicare: Not Enrolled in Medicare Practice Location: 910 17th St Nw Ste 419, Washington, DC 20006 Phone: 202-505-2795 | |
Dr. Megan Laabs, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 202-782-8671 | |
Dana Footer, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Dr. Jennifer Lee Bakalar, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2000 P St Nw Ste 408, Washington, DC 20036 Phone: 202-932-0893 | |
Dr. Karin Leah Arndt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4601 Connecticut Ave Nw, Suite 20, Washington, DC 20008 Phone: 716-239-0723 | |
Renee Michelle Neely-walters, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5800 8th St Nw, Washington, DC 20011 Phone: 202-541-6608 |